Delfzijl, The Netherlands, 18 December 2012 - Today, a consortium consisting of BioMCN, Siemens, Linde, and Visser & Smit Hanab, received 199 million euros in NER300 grants. With these funds, a large-scale biomass refinery will be constructed.
This initiative, also known as the Woodspirit project, will make a significant contribution to the availability of sustainable and advanced biofuels, and to the biobased economy in the Netherlands.
"We are proud and delighted that the European Commission has allocated funding to this project. These grants clearly demonstrate the EC's support for the availability of more sustainable biofuels and renewable chemical materials. This project will have an important positive impact on the reduction of CO2 emissions and on meeting the 2020 climate objectives", says Rob Voncken, CEO of BioMCN
In the framework of the European NER300 program, the Woodspirit partnership submitted a grant application to the Dutch Ministry of Economic Affairs on February 9th 2011. The European NER300 program provides financial resources for large-scale innovative renewable energy projects.
"Woodspirit delivers a significant contribution to the development of biofuels," says minister Kamp of Economic Affairs. "Moreover, the partnership will boost economic activity in the North of the Netherlands."
The refinery produces biobased chemicals and biofuels from biomass that consists of residues from the forestry and the wood processing industries.
After a process of desiccation, reduction and torrefaction, the biomass is fed into a gasification plant. Here the biomass is converted into raw synthesis gas, better known as syngas. After cleaning the syngas is converted into biomethanol.
The construction of this project will provide a major boost to the economic development in the northeast part of the Province of Groningen and is supported by various parties, including the Province of Groningen, N.V. NOM, Stichting Energy Valley, N.V. Nederlandse Gasunie and Groningen Seaports.
With the awarding of the subsidy the development of the Woodspirit installation can continue and the licensing and decision-making process can be finalised. The subsidy will allow the consortium to further refine and shape agreements regarding the total estimated investment of 500 million Euros. The project will take approximately four years to complete.
 Visser & Smit Hanab is part of VolkerWessels
 NER300 is a financing instrument managed jointly by the European Commission, European Investment Bank and Member States, so-called because Article 10(a) 8 of the revised Emissions Trading Directive 2009/29/EC contains the provision to set aside 300 million allowances (rights to emit one tonne of carbon dioxide) in the New Entrants' Reserve of the European Emissions Trading Scheme for subsidising installations of innovative renewable energy technology and carbon capture and storage (CCS). The allowances will be sold on the carbon market and the money raised will be made available to projects as they operate.
On 1 November 2012, Waterland opened its definitive offices in Warsaw (Poland). The office is conveniently located on Plac Trzech Krzyzy 18, 00-499 Warsaw, Poland.
Sarens Group executed last weekend the transportation of perhaps its most valuable cargo to date: the space shuttle Endeavour. The enormous but highly fragile space craft began its 14-mile overland journey from Los Angeles International Airport to the California Science Center at midnight on Friday night the 12th of October, and arrived approximately 48 hours later.
Accustomed to reaching speeds of up to 28 000 kph in space, the space shuttle Endeavour was reduced to a crawling 3 kph as it made its way through Los Angeles en route for Inglewood City Hall for an official launch ceremony before reaching its final destination at the California Science Center.
The Endeavour's "final mission" was the result of months of meticulous planning by Sarens engineers in collaboration with multitude of public and private entities. An array of specially designed, Self-Propelled Modular Trailers (SPMTs) were used to transport the Endeavour. Comprising four independent, multi-axle, computer-controlled wheeled vehicles, the SPMTs will ensure precision manoeuvrability and stability while moving the shuttle along its densely populated route.
The SPMTs are controlled and steered as a single vehicle by a person walking alongside the shuttle using a remote joystick control panel. Additional spotters will be positioned near the nose, tail and wingtips to enable precision manoeuvrability near potential obstructions such as buildings, poles and trees. This was the first and most likely the only time that a space shuttle was or will be transported through an urban environment.
Jim Hennessy, Marketing Manager, Sarens North America: "This may not be the largest or heaviest object we have transported before but it is certainly one of the most important in our company's history. The Endeavour is a national treasure and we are honoured to play a key role in its final mission en route to the California Science Center where it will be put on display for all to see."
The shuttle weighs 68 tonnes, has a wingspan of 24m tip to tip, is 38m long and measures 17m from the ground to the tip of the tail. In preparation for its transport, several high-voltage transmission lines were either removed or repositioned along with hundreds of streetlights, signs, traffic signals and identified obstacles.
The Endeavour has flown 25 successful missions, travelled nearly 200 million km, spent 299 days in space and circled the earth 4671 times.
The transaction will significantly strengthen Omega Pharma’s product portfolio and will create critical mass for the company in key markets including Germany, the UK, Poland and Italy.
Nazareth (Belgium) – 15 March 2012 (10:30 a.m. CET). Omega Pharma today announces that it has reached agreement to acquire the previously identified non-core OTC brands of GlaxoSmithKline (GSK) in Europe for EUR 470 million (GBP391 million) in cash. This transaction builds on the recently announced divestment by GSK of certain non-core OTC brands in the USA and Canada, the majority of which was completed at the end of January 2012.
The brands being acquired include Lactacyd, Abtei, Solpadeine, Zantac, Nytol and Beconase and generated sales of over EUR 200 million in 2011. The transaction is expected to be completed in the second quarter of 2012, subject to regulatory approvals.
As part of the agreement, Omega has also agreed to purchase the Herrenberg manufacturing site which is located in Germany and employs approximately 110 people. A number of the brands that are being acquired are manufactured at Herrenberg and it is anticipated that existing employees will transfer with the site to Omega Pharma under the provisions of German employment law.
Omega Pharma’s Chief Executive Officer, Marc Coucke commented: “We are very happy with this agreement, which testifies the mutual vision and commitment of Omega Pharma and Waterland, which recently became Omega Pharma’s equity partner. Several brands from the acquisition will become part of Omega Pharma’s top-20 brands, and all of the brands that are the subject to today’s announcement have the potential to grow within our group. The proposed transaction will also provide Omega Pharma with the required critical mass in a number of key European markets – i.e. Germany, the UK, Poland and Italy. We also look forward to welcoming the employees of the Herrenberg site, whose contribution will further strengthen the manufacturing capabilities of our group, to Omega Pharma.”
Omega Pharma is an OTC healthcare company headquartered in Nazareth (Belgium) with operations in 35 countries across Europe and selected emerging markets. Its products are sold across an extensive network of pharmacies and related retail outlets. For further information please visit www.omega-pharma.com.
GlaxoSmithKline is one of the world’s leading research-based pharmaceutical and healthcare companies. It is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.
Die holländische Beteiligungsgesellschaft Waterland führt das zum dritten Mal erscheinende HEC-Dow Jones Private Equity Performance Ranking an, welches jährlich von Professor Gottschalg von der HEC Business School Paris für Private Equity News erstellt wird.
For details please go to http://www.unquote.com/unquote/analysis/2110565/unquote-awards-winners-announced
Waterland is Benelux Private Equity Firm of the Year 2011 by Private Equity News / Dow Jones. Private Equity News / Dow Jones commented as follows:
"The Dutch mid-market buyout firm has established a reputation as a strong performer and was ranked third in a study of the best-performing firms by business school HEC Paris. During 2010, Waterland bought direct marketing company Ranger Marketing and acquired the Benelux companies of gym company Fitness First. It also backed Waeyaert-Vermeersch Isolatie group, a Belgian distributor of insulation materials."
Waterland Private Equity Investments B.V. ("Waterland") is pleased to announce the final closing of its fifth institutional fund, Waterland Private Equity Fund V ("WPEF V"), at €1.1 billion, just five months after its initial launch. The support of existing investors combined with significant interest from new investors, caused the fund to be well oversubscribed, surpassing its initial target of €900 million.
- 1 2 3 4 Nächster »